首页> 美国卫生研究院文献>other >In silico model-based inference: an emerging approach for inverse problems in engineering better medicines
【2h】

In silico model-based inference: an emerging approach for inverse problems in engineering better medicines

机译:基于计算机模型的推理:工程更好的药物中逆问题的新兴方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Identifying the network of biochemical interactions that underpin disease pathophysiology is a key hurdle in drug discovery. While many components involved in these biological processes are identified, how components organize differently in health and disease remains unclear. In chemical engineering, mechanistic modeling provides a quantitative framework to capture our understanding of a reactive system and test this knowledge against data. Here, we describe an emerging approach to test this knowledge against data that leverages concepts from probability, Bayesian statistics, and chemical kinetics by focusing on two related inverse problems. The first problem is to identify the causal structure of the reaction network, given uncertainty as to how the reactive components interact. The second problem is to identify the values of the model parameters, when a network is known a priori.
机译:识别支持疾病病理生理的生化相互作用网络是药物发现的关键障碍。虽然确定了这些生物过程中涉及的许多组成部分,但尚不清楚这些组成部分如何在健康和疾病中以不同的方式组织。在化学工程中,机械建模提供了一个定量框架,以捕获我们对反应性系统的理解并针对数据测试此知识。在这里,我们描述了一种新兴的方法,可以通过关注两个相关的逆问题来对照利用概率,贝叶斯统计和化学动力学等概念的数据来测试该知识。第一个问题是在给定反应性组分如何相互作用的不确定性的情况下,确定反应网络的因果结构。第二个问题是在先验已知网络时识别模型参数的值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号